Taiwan Bio’s SuperCarrier MSC is a cutting-edge, genetically engineered cell therapy with an unparalleled growth factor or cytokine secretion ability.
MSC-VEGF: our first SuperCarrier MSC
Improving angiogenesis and restoring local blood flow to
treat ischaemic diseases
![](https://twbio-thera.com/wp-content/uploads/2022/09/pipe2.jpg)
MSC-VEGF: our first SuperCarrier MSC
Improving angiogenesis and restoring local blood flow to treat ischaemic diseases
![](https://twbio-thera.com/wp-content/uploads/2022/09/pipe-2.jpg)
Our portfolio
We aim to bring new hope to patients with our novel
platform technologies and creative approaches
Pipeline
MSC_VEGF
Critical limb ischemia|Genetic engineered
![](https://twbio-thera.com/wp-content/uploads/2022/05/4c.jpg)
![](https://twbio-thera.com/wp-content/uploads/2022/03/lable-1.jpg)
TBPCB201
Acute myocardial infarction | Precision cell bank
![](https://twbio-thera.com/wp-content/uploads/2022/09/newline.jpg)
![](https://twbio-thera.com/wp-content/uploads/2022/03/lable-1.jpg)
Biochymal
Unhealed wound caused by CLI | Hypoxia-preconditioned
![](https://twbio-thera.com/wp-content/uploads/2022/04/1c.jpg)
![](https://twbio-thera.com/wp-content/uploads/2022/03/lable-1.jpg)
Chondrochymal
OA | Hypoxia-preconditioned
![](https://twbio-thera.com/wp-content/uploads/2022/04/1c.jpg)
![](https://twbio-thera.com/wp-content/uploads/2022/03/lable-1.jpg)
Our portfolio
We aim to bring new hope to patients with our novel platform technologies and creative approaches
Pipeline
MSC_VEGF
Critical limb ischemia|Genetic engineered
![](https://twbio-thera.com/wp-content/uploads/2022/05/pre-2.jpg)
TWB201
Acute myocardial infarction | Precision cell bank
![](https://twbio-thera.com/wp-content/uploads/2022/09/newpm.jpg)
Biochymal
Unhealed wound caused by CLI | Hypoxia-preconditioned
![](https://twbio-thera.com/wp-content/uploads/2022/05/phase2b-1.jpg)
Chondrochymal
OA | Hypoxia-preconditioned
![](https://twbio-thera.com/wp-content/uploads/2022/05/phase2b-1.jpg)